Galecto, Inc. (GLTO) Financial Statements
Industry: Pharmaceutical Preparations
In fiscal 2025, Galecto reported revenue of $0. Net income was -$209.8M, or $3.98 per diluted share. Operating activities generated -$6.7M of cash, leaving -$6.7M of free cash flow. At fiscal year end, Galecto held $260.5M in total assets against $20.1M in total liabilities, including $257.6M of cash and equivalents.
Open the full interactive Galecto financials → Quarterly statements, key ratios, valuation history and price charts.
Galecto Key Stats
| Share Price | $18.56 |
|---|---|
| Market Cap | $1.13B |
| P/E Ratio | 4.7 |
| 52-Week Range | $4.95 – $34.14 |
| Shares Outstanding | 61.1 million (basic, 2026 Q2) |
Galecto Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating Income | $33.6M | -$52.2M | -$61.2M | -$39.9M | -$22.3M | -$210.9M |
| Pre-Tax Income | -$34.8M | -$51.8M | -$61.6M | -$38.3M | -$21.4M | -$209.8M |
| Income Tax | $0 | $0 | $0 | $0 | $41,000 | $50,000 |
| Net Income | -$34.8M | -$51.8M | -$61.6M | -$38.3M | -$21.4M | -$209.8M |
| Diluted EPS | -$190.50 | -$51.25 | -$60.75 | -$36.00 | -$18.53 | $3.98 |
Galecto Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Net Income | -$3.1M | -$200.7M | -$27.8M | -$31.2M |
| Diluted EPS | -$2.36 | -$147.27 | -$0.62 | -$0.39 |
Galecto Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $163.6M | $62.6M | $32.8M | $21.5M | $14.2M | $257.6M |
| Current Assets | $169.3M | $110.1M | $63.9M | $36.8M | $16.8M | $260.4M |
| Total Assets | $171.6M | $122.2M | $73.2M | $38.2M | $17.1M | $260.5M |
| Current Liabilities | $5.6M | $4.5M | $11.1M | $5.8M | $1.2M | $20.1M |
| Total Liabilities | $6.1M | $5.0M | $11.4M | $5.9M | $1.3M | $20.1M |
| Shareholders' Equity | $165.5M | $117.2M | $61.8M | $32.3M | $15.8M | $240.4M |
Galecto Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$38.2M | -$52.3M | -$42.9M | -$36.9M | -$18.6M | -$6.7M |
| Cash From Investing | — | -$48.0M | $12.4M | $22.3M | $11.7M | -$17.4M |
| Cash From Financing | $187.4M | — | $507,000 | $2.9M | — | $266.8M |
| Free Cash Flow | — | -$52.5M | -$43.1M | -$36.9M | -$18.6M | -$6.7M |
Figures from Galecto's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Galecto financials page for every line item.
Galecto Company Profile
| Ticker | GLTO |
|---|---|
| Exchange | Nasdaq |
| Industry | Pharmaceutical Preparations |
| Headquarters | Waltham, Massachusetts |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Non-accelerated filer, smaller reporting company |
| SEC CIK | 0001800315 |
Frequently Asked Questions
What was Galecto's revenue in fiscal 2025?
Galecto (GLTO) reported revenue of $0 for fiscal 2025.
What is Galecto's annual revenue history?
Galecto's annual revenue by fiscal year: 2020: $0; 2021: $0; 2022: $0; 2023: $0; 2024: $0; 2025: $0.
What was Galecto's net income in fiscal 2025?
Galecto reported net income of -$209.8M for fiscal 2025.
What was Galecto's earnings per share (EPS) in fiscal 2025?
Galecto's diluted EPS was $3.98 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Galecto generate in fiscal 2025?
Galecto generated -$6.7M of free cash flow in fiscal 2025.
What was Galecto's revenue last quarter?
In its most recent reported quarter (2026 Q2), Galecto reported revenue of $0.
How many shares of Galecto are outstanding?
Galecto reported a weighted average of 61.1 million basic shares outstanding in 2026 Q2.
What is Galecto's market cap?
Based on its latest closing price, Galecto (GLTO) has a market capitalization of about $1.13B.
When does Galecto's fiscal year end?
Galecto's fiscal year end, as registered with the SEC, is December 31.
Where is Galecto headquartered?
Galecto lists its business address in Waltham, Massachusetts in its SEC filings.